Louis Bont, MD, PhD, is a Pediatric Infectiologist-Immunologist and the head of the Pediatric Department at the University Medical Center Utrecht, The Netherlands. He is the founding chairman of ReSViNET, an international respiratory syncytial virus (RSV) research consortium. His specific research interests include RSV pathogenesis and the burden of disease.
Dr. Bont's work focuses on unraveling the role of neutrophils, RSV-related mortality, and long-term airway disease following RSV infection. He is the lead investigator of the INFORM study, a large prospective global clinical virology study that aims to uncover the molecular epidemiology of RSV in over 2000 children. He also leads the RSV GOLD mortality registry, funded by the Bill and Melinda Gates Foundation.
His group collaborates with the World Health Organization on RSV surveillance and vaccine development. Dr. Bont’s research emphasizes clinical and translational mechanisms of disease and the identification of intervention targets for RSV bronchiolitis. He has been the lead author of over 300 publications in peer-reviewed medical journals.
Additionally, he founded the Training of Upcoming Leaders in Pediatric Science (TULIPS), a career training network for clinician scientists in the field of Child Health.